Austria
· Delayed Price · Currency is EUR Marinomed Biotech AG Statistics
Total Valuation
VIE:MARI has a market cap or net worth of EUR 21.61 million. The enterprise value is 49.18 million.
| Market Cap | 21.61M |
| Enterprise Value | 49.18M |
Important Dates
The last earnings date was Wednesday, April 16, 2025.
| Earnings Date | Apr 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VIE:MARI has 1.78 million shares outstanding. The number of shares has increased by 17.14% in one year.
| Current Share Class | 1.78M |
| Shares Outstanding | 1.78M |
| Shares Change (YoY) | +17.14% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 29.54% |
| Owned by Institutions (%) | 26.20% |
| Float | 1.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.51 |
| PB Ratio | -0.83 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.19 |
| EV / Sales | 10.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -42.55% |
| Return on Invested Capital (ROIC) | -72.25% |
| Return on Capital Employed (ROCE) | 30.01% |
| Revenue Per Employee | 122,893 |
| Profits Per Employee | -395,292 |
| Employee Count | 52 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 5.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.49% in the last 52 weeks. The beta is -0.21, so VIE:MARI's price volatility has been lower than the market average.
| Beta (5Y) | -0.21 |
| 52-Week Price Change | -27.49% |
| 50-Day Moving Average | 13.35 |
| 200-Day Moving Average | 11.45 |
| Relative Strength Index (RSI) | 43.34 |
| Average Volume (20 Days) | 889 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VIE:MARI had revenue of EUR 4.79 million and -15.42 million in losses. Loss per share was -8.67.
| Revenue | 4.79M |
| Gross Profit | 1.03M |
| Operating Income | -6.99M |
| Pretax Income | -15.52M |
| Net Income | -15.42M |
| EBITDA | -6.58M |
| EBIT | -6.99M |
| Loss Per Share | -8.67 |
Balance Sheet
The company has 1.71 million in cash and 29.28 million in debt, giving a net cash position of -27.57 million or -15.50 per share.
| Cash & Cash Equivalents | 1.71M |
| Total Debt | 29.28M |
| Net Cash | -27.57M |
| Net Cash Per Share | -15.50 |
| Equity (Book Value) | -26.16M |
| Book Value Per Share | -14.71 |
| Working Capital | -28.20M |
Cash Flow
| Operating Cash Flow | -2.40M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 21.40% |
| Operating Margin | -145.90% |
| Pretax Margin | -323.72% |
| Profit Margin | n/a |
| EBITDA Margin | -137.28% |
| EBIT Margin | -145.90% |
| FCF Margin | n/a |
Dividends & Yields
VIE:MARI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.14% |
| Shareholder Yield | -17.14% |
| Earnings Yield | -71.35% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VIE:MARI has an Altman Z-Score of -18.09. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.09 |
| Piotroski F-Score | n/a |